Individual effect of renin-angiotensin system inhibition and corticosteroid therapy in IgA glomerulonephritis : results of a pilot study

The impact of different therapy modalities on the outcome of Immunoglobulin A glomerulonephritis (IgAGN) in individual patient is not clear. We present preliminary results from the sequential application of renin-angiotensin system (RAS) inhibition and corticosteroids to discriminate the individual effect of both therapies.